Physician profile
Theodore John Constantine
NPI 1982753182
$2,844.03
in general payments reported to CMS, 2019-2025
9 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 96% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.68 · 2021: $350 · 2022: $606 · 2023: $702 · 2024: $32.98 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,544 · Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,544.45 |
| Food and Beverage | $294.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,554.25 | 2022-2025 | Opalescence |
| A-Dec, INC. | $575.00 | 2025 | |
| Straumann USA LLC | $360.86 | 2021-2025 | |
| Dentsply Sirona INC | $122.92 | 2023-2025 | Waveone Gold Conform Fit, Cerec |
| Centrix INC | $72.00 | 2021 | |
| Southern Implants North America INC | $68.45 | 2023 | |
| Dexcel Pharma Technologies LTD. | $48.68 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $29.20 | 2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Constantine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.